These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 2690475)

  • 1. Comparison of assay procedures used to measure total and unbound concentrations of quinidine.
    Wooding-Scott RA; Darling IM; Slaughter RL
    DICP; 1989 Dec; 23(12):999-1004. PubMed ID: 2690475
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evaluation of a rapid ultrafiltration technique for determination of quinidine protein binding and comparison with equilibrium dialysis.
    Ha HR; Vozeh S; Follath F
    Ther Drug Monit; 1986; 8(3):331-5. PubMed ID: 3529516
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Quinidine assays: enzyme immunoassay versus high performance liquid chromatography.
    Lehmann CR; Boran KJ; Pierson WP; Melikian AP; Wright GJ
    Ther Drug Monit; 1986; 8(3):336-9. PubMed ID: 3529517
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Liquid chromatography and fluorescence spectroscopy compared with a homogeneous enzyme immunoassay technique for determining quinidine in serum.
    Drayer DE; Lorenzo B; Reidenberg MM
    Clin Chem; 1981 Feb; 27(2):308-10. PubMed ID: 7006859
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Factors affecting the binding of disopyramide to serum proteins.
    Shaw LM; Altman R; Thompson BC; Fields L
    Clin Chem; 1985 Apr; 31(4):616-9. PubMed ID: 3884182
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Influence of the ORM1 phenotypes on serum unbound concentration and protein binding of quinidine.
    Li JH; Xu JQ; Cao XM; Ni L; Li Y; Zhuang YY; Gong JB
    Clin Chim Acta; 2002 Mar; 317(1-2):85-92. PubMed ID: 11814462
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Determination of free disopyramide plasma concentrations using ultrafiltration and enzyme multiplied immunoassay.
    Raghow G; Meyer MC; Straughn AB
    Ther Drug Monit; 1985; 7(4):466-71. PubMed ID: 3909539
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The EMIT FreeLevel ultrafiltration technique compared with equilibrium dialysis and ultracentrifugation to determine protein binding of phenytoin.
    Oellerich M; Müller-Vahl H
    Clin Pharmacokinet; 1984 Jan; 9 Suppl 1():61-70. PubMed ID: 6705428
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Measurement of lidocaine free concentration.
    Beach CL; Ludden TM; Clementi WA; Allerheiligen SR
    Ther Drug Monit; 1986; 8(3):326-30. PubMed ID: 3529515
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparison of high pressure liquid chromatography and fluorescence polarization immunoassay to assess quinidine pharmacokinetics.
    Bottorff MB; Lalonde RL; Straughn AB
    Biopharm Drug Dispos; 1987; 8(3):213-21. PubMed ID: 3297181
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Analysis of caffeine: comparison of the manual enzyme multiplied immunoassay (EMIT), automated EMIT, and high-performance liquid chromatography procedures.
    Miceli JN; Aravind MK; Ferrell WJ
    Ther Drug Monit; 1984; 6(3):344-7. PubMed ID: 6390796
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Ultrafiltration compared with equilibrium dialysis in the determination of unbound phenytoin in plasma.
    Koike Y; Magnusson A; Steiner E; Rane A; Sjöqvist F
    Ther Drug Monit; 1985; 7(4):461-5. PubMed ID: 3909538
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The application of a microcomputer for enzyme immunoassay (Emit) determination of serum quinidine concentrations.
    Sealfon MS; Hallberg N
    Am J Med Technol; 1983 Sep; 49(9):669-70. PubMed ID: 6372484
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Blood collection techniques, heparin and quinidine protein binding.
    Kessler KM; Leech RC; Spann JF
    Clin Pharmacol Ther; 1979 Feb; 25(2):204-10. PubMed ID: 759074
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Altered therapeutic range for quinidine after myocardial infarction and cardiac surgery.
    Garfinkel D; Mamelok RD; Blaschke TF
    Ann Intern Med; 1987 Jul; 107(1):48-50. PubMed ID: 3109296
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Simultaneous analysis of antiarrhythmic drugs and metabolites by high performance liquid chromatography: interference studies and comparisons with other methods.
    Wesley JF; Lasky FD
    Clin Biochem; 1982 Dec; 15(6):284-90. PubMed ID: 6762929
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Determination of total and free phenytoin in serum by non-isotopic immunoassays and gas chromatography.
    Külpmann WR; Gey S; Beneking M; Kohl B; Oellerich M
    J Clin Chem Clin Biochem; 1984 Nov; 22(11):773-9. PubMed ID: 6396367
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Determination of amprenavir total and unbound concentrations in plasma by high-performance liquid chromatography and ultrafiltration.
    Barrail A; Le Tiec C; Paci-Bonaventure S; Furlan V; Vincent I; Taburet AM
    Ther Drug Monit; 2006 Feb; 28(1):89-94. PubMed ID: 16418700
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Decreased quinidine plasma protein binding during hemodialysis.
    Kessler KM; Perez GO
    Clin Pharmacol Ther; 1981 Jul; 30(1):121-6. PubMed ID: 7237891
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Enzyme immunoassay and two fluorometric methods compared for the determination of quinidine in serum.
    Pape BE
    Ther Drug Monit; 1981; 3(4):357-63. PubMed ID: 7039008
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.